Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

Fig. 1

Validation of the elevated serum levels of soluble POSTN in patients with BCa Scatter plots for POSTN, CA153 and CEA in the POSTN (A), CA153 (B), and CEA (C), respectively. For each marker in the dataset, three groups were included: healthy controls (Healthy, n = 69), locoregional BCa (LR BCa, n = 115) and distant BCa (DSNT BCa, n = 58)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us